Safety Tolerability and Efficacy of Intravitreal LMG324 in the Treatment of Neovascular Age-Related Macular Degeneration
Clinical trial NCT02398500 · TERMINATED
Trial details
- NCT number
- NCT02398500
- Sponsor
- Alcon Research
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-07-22
- Primary completion
- 2016-02-29
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.